SCHEMBL380554

SCHEMBL380554

CC(=O)C(C)(C(=O)O)C(C)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
TP53 P04637 1/20 0.35
TSHR P16473 1/20 0.35
MAPT P10636 1/20 0.31
PTGS1 P23219 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4206119 0.87 ALDH1A1 (0.40) ALDH1A1TP53TSHRMAPTPTGS1
SCHEMBL9517358 0.83 TDP1 (0.30)
SCHEMBL25787072 0.79 TSHR (0.38) ALDH1A1TP53TSHR
SCHEMBL28486 0.73 TP53 (0.42) ALDH1A1TP53TSHRMAPTPTGS1
SCHEMBL4614092 0.71 ALDH1A1 (0.32) ALDH1A1TSHR
SCHEMBL17407606 0.70 ALDH1A1 (0.40) ALDH1A1TP53TSHRMAPTPTGS1
SCHEMBL2784566 0.70 ALDH1A1 (0.40) ALDH1A1TP53TSHRMAPTPTGS1
SCHEMBL7326571 0.70 ALDH1A1 (0.40) ALDH1A1TP53TSHRMAPTPTGS1
SCHEMBL2230034 0.69 ALDH1A1 (0.44) ALDH1A1TP53TSHRMAPTPTGS1
SCHEMBL125061 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2976369-B1 FREE-RADICAL POLYMERIZATION METHODS AND ARTICLES PREPARED THEREBY 3M INNOVATIVE PROPERTIES CO (US) 2018-02-07 EP claimed
EP-2516008-B1 NOVEL ANTIVIRAL COMPOUNDS UNIV LEUVEN KATH (BE) 2014-04-16 EP disclosed
US-20120316161-A1 NOVEL ANTIVIRAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2012-12-13 US disclosed
EP-2516008-A1 NOVEL ANTIVIRAL COMPOUNDS Katholieke Universiteit Leuven (BE) 2012-10-31 EP disclosed
EP-2411494-A2 METHOD AND COMPOSITION FOR CLEANING OBJECTS Bubbles and Beyond GmbH (DE) 2012-02-01 EP disclosed
EP-2408429-A2 PREPARATION FOR EXTERNAL APPLICATION Bubbles and Beyond GmbH (DE) 2012-01-25 EP disclosed
WO-2011076765-A1 NOVEL ANTIVIRAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2011-06-30 WO disclosed
WO-2010108639-A2 METHOD AND COMPOSITION FOR CLEANING OBJECTS BUBBLES AND BEYOND GMBH (DE) 2010-09-30 WO disclosed
WO-2010105842-A2 PREPARATION FOR EXTERNAL APPLICATION BUBBLES AND BEYOND GMBH (DE) 2010-09-23 WO disclosed
EP-2223995-A2 Formulas for removing paint layers and diverse dirt coatings on surfaces, method for manufacturing the agent and cleaning method Bubbles and Beyond GmbH (DE) 2010-09-01 EP disclosed
EP-2195408-A2 FORMULA FOR REMOVING COLOR COATS AND VARIOUS SOIL LAYERS FROM SURFACES, METHOD FOR PRODUCING THE AGENT, AND METHOD FOR CLEANING Bubbles & Beyond Gmbh (DE) 2010-06-16 EP disclosed
WO-2009037349-A2 FORMULA FOR REMOVING COLOR COATS AND VARIOUS SOIL LAYERS FROM SURFACES, METHOD FOR PRODUCING THE AGENT, AND METHOD FOR CLEANING BUBBLES & BEYOND GMBH (DE) 2009-03-26 WO disclosed
EP-1483442-A2 NOVEL CATALYTIC ACTIVITIES OF OXIDOREDUCTASES FOR OXIDATION AND/OR BLEACHING Call, Krimhild (DE) 2004-12-08 EP disclosed
EP-1436371-A2 ENZYMATIC SYSTEMS FOR GENERATING ACTIVE OXYGEN SPECIES FOR REACTING WITH OTHER PRECURSORS TO OBTAIN OXIDATION AND/OR BLEACHING Call, Krimhild (DE) 2004-07-14 EP disclosed
WO-2003061550-A2 NOVEL CATALYTIC ACTIVITIES OF OXIDOREDUCTASES FOR OXIDATION AND/OR BLEACHING CALL, KRIMHILD (DE) 2003-07-31 WO disclosed
WO-2002099023-A2 ENZYMATIC SYSTEMS FOR GENERATING ACTIVE OXYGEN SPECIES FOR REACTING WITH OTHER PRECURSORS TO OBTAIN OXIDATION AND/OR BLEACHING CALL, KRIMHILD (DE) 2002-12-12 WO disclosed
EP-1012376-A2 OXIDATION AND BLEACHING SYSTEM WITH ENZYMATICALLY PRODUCED OXIDIZING AGENTS Blume, Hildegard (DE) 2000-06-28 EP disclosed
WO-1998059108-A2 OXIDATION AND BLEACHING SYSTEM WITH ENZYMATICALLY PRODUCED OXIDIZING AGENTS BLUME, HILDEGARD (DE) 1998-12-30 WO disclosed
EP-0401532-B1 PROCESS FOR THE PREPARATION OF A STORAGE STABLE LEVULINIC ACID Chemie Linz Gesellschaft m.b.H. (AT) 1993-03-24 EP disclosed
EP-0401532-A1 Process for the preparation of a storage stable levulinic acid Chemie Linz Gesellschaft m.b.H. (AT) 1990-12-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120316161-A1 NOVEL ANTIVIRAL COMPOUNDS MAVS, EIF2AK2, ZC3HAV1 ALDH1A1 1275/4885TP53 4179/4885TSHR 4872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.